UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology of cutaneous porphyria in Israel: a nationwide cohort study

Journal of the European Academy of Dermatology and Venereology, 2020-01, Vol.34 (1), p.184-187

2020

Volltextzugriff (PDF)

Systemic lupus erythematosus exacerbation following cessation of belimumab treatment

Scandinavian journal of rheumatology, 2016-03, Vol.45 (2), p.103-106

2016

Volltextzugriff (PDF)

Increased ERK and JNK activities correlate with disease activity in patients with systemic lupus erythematosus

Annals of the rheumatic diseases, 2010-01, Vol.69 (1), p.175-180

2010

Volltextzugriff (PDF)

Constitutive abnormal expression of RasGRP-1 isoforms and low expression of PARP-1 in patients with systemic lupus erythematosus

Lupus, 2011-12, Vol.20 (14), p.1501-1509

2011

Volltextzugriff (PDF)

Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies

Lupus, 2005-02, Vol.14 (2), p.145-151

2005

Volltextzugriff (PDF)

Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort

Lupus, 2002-01, Vol.11 (6), p.356-361

2002

Volltextzugriff (PDF)

Soluble triggering receptor expressed on myeloid cells-1 for distinguishing bacterial from aseptic meningitis in adults

European journal of clinical microbiology & infectious diseases, 2007-09, Vol.26 (9), p.647-650

2007

Volltextzugriff (PDF)

Childhood Behçet's disease : clinical features and comparison with adult-onset disease

Rheumatology (Oxford, England), 1999-05, Vol.38 (5), p.457-462

1999

Volltextzugriff (PDF)

Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)

Annals of the rheumatic diseases, 2015-11, Vol.74 (11), p.2006-2015

2015

Volltextzugriff (PDF)

Spontaneous retroperitoneal bleeding from renal microaneurysms and pancreatic pseudocyst in a patient with systemic lupus erythematosus

Scandinavian journal of rheumatology, 2006-01, Vol.35 (6), p.481-484

2006

Volltextzugriff (PDF)

Urine soluble triggering receptor expressed on myeloid cells-1 is a novel biomarker for active lupus nephritis: a case-control study

Clinical and experimental rheumatology, 2023-05, Vol.41 (5), p.1155

2023

Volltextzugriff (PDF)

POS1198 EPIDEMIOLOGY OF VEXAS SYNDROME IN ISRAEL – A HIGH PREVALENCE OF UBA1 p.M41V PATHOGENIC VARIANT IN ISRAELI VEXAS PATIENTS

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.548-549

2024

Volltextzugriff (PDF)

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

The Lancet (British edition), 2008-03, Vol.371 (9617), p.987-997

2008

Volltextzugriff (PDF)

Primary anetoderma: a cutaneous sign of antiphospholipid antibodies

Lupus, 2003-01, Vol.12 (7), p.564-568

2003

Volltextzugriff (PDF)

Severe digital ischemia–a presenting symptom of malignancy–associated antiphospholipid syndrome

Lupus, 2008-03, Vol.17 (3), p.206-209

2008

Volltextzugriff (PDF)

Increased ERK and JNK activation and decreased ERK/JNK ratio are associated with long-term organ damage in patients with systemic lupus erythematosus

Rheumatology (Oxford, England), 2014-06, Vol.53 (6), p.1034-1042

2014

Volltextzugriff (PDF)

Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) Relapsing as Bullous Eruption

Acta dermato-venereologica, 2017-03, Vol.97 (3), p.406-407

2017

Volltextzugriff (PDF)

Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial

Journal of rheumatology, 2008-01, Vol.35 (1), p.41

2008

Volltextzugriff (PDF)

Authors' reply

Scandinavian journal of rheumatology, 2017-05, Vol.46 (3), p.251-252

2017

Volltextzugriff (PDF)

Authors’ reply

Scandinavian journal of rheumatology, 2017-05, Vol.46 (3), p.251-252

2017

Volltextzugriff (PDF)

Pathergy reaction in Behçet's disease: lack of correlation with mucocutaneous manifestations and systemic disease expression

Clinical and experimental rheumatology, 2000-01, Vol.18 (1), p.71

2000

Volltextzugriff (PDF)

Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): Immunomodulation of gene expression

Journal of autoimmunity, 2009-08, Vol.33 (1), p.77-82

2009

Volltextzugriff (PDF)

Disease patterns of patients with Behçet's disease demonstrated by factor analysis

Clinical and experimental rheumatology, 1999-05, Vol.17 (3), p.347

1999

Volltextzugriff (PDF)

A central role of plasmin in cardiac injury initiated by fetal exposure to maternal anti-Ro autoantibodies

Rheumatology (Oxford, England), 2013-08, Vol.52 (8), p.1448-1453

2013

Volltextzugriff (PDF)

Headache in systemic lupus erythematosus and its relation to other disease manifestations

Clinical and experimental rheumatology, 1999-07, Vol.17 (4), p.467

1999

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Englisch
(88)
Hebräisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(64)
Humans
(59)
Female
(46)
Male
(36)
Biological And Medical Sciences
(35)
Adult
(33)
Middle Aged
(30)
Medical Sciences
(29)
Rheumatology
(29)
Aged
(19)
Adolescent
(15)
Severity Of Illness Index
(15)
Animals
(14)
Systemic Lupus Erythematosus
(12)
Fundamental And Applied Biological Sciences. Psychology
(9)
Lupus
(9)
Cattle
(8)
Molecular Sequence Data
(8)
Prospective Studies
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidemiology of cutaneous porphyria in Israel: a nationwide cohort study

Systemic lupus erythematosus exacerbation following cessation of belimumab treatment

Increased ERK and JNK activities correlate with disease activity in patients with systemic lupus erythematosus

Constitutive abnormal expression of RasGRP-1 isoforms and low expression of PARP-1 in patients with systemic lupus erythematosus

Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies

Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort

Soluble triggering receptor expressed on myeloid cells-1 for distinguishing bacterial from aseptic meningitis in adults

Childhood Behçet's disease : clinical features and comparison with adult-onset disease

Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)

Spontaneous retroperitoneal bleeding from renal microaneurysms and pancreatic pseudocyst in a patient with systemic lupus erythematosus

Urine soluble triggering receptor expressed on myeloid cells-1 is a novel biomarker for active lupus nephritis: a case-control study

POS1198 EPIDEMIOLOGY OF VEXAS SYNDROME IN ISRAEL – A HIGH PREVALENCE OF UBA1 p.M41V PATHOGENIC VARIANT IN ISRAELI VEXAS PATIENTS

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Primary anetoderma: a cutaneous sign of antiphospholipid antibodies

Severe digital ischemia–a presenting symptom of malignancy–associated antiphospholipid syndrome

Increased ERK and JNK activation and decreased ERK/JNK ratio are associated with long-term organ damage in patients with systemic lupus erythematosus

Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) Relapsing as Bullous Eruption

Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial

Authors' reply

Authors’ reply

Pathergy reaction in Behçet's disease: lack of correlation with mucocutaneous manifestations and systemic disease expression

Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): Immunomodulation of gene expression

Disease patterns of patients with Behçet's disease demonstrated by factor analysis

A central role of plasmin in cardiac injury initiated by fetal exposure to maternal anti-Ro autoantibodies

Headache in systemic lupus erythematosus and its relation to other disease manifestations

Suchergebnisse filtern